Order Article Reprints

Poret B, Desrues L, Bonin M-A, Pedard M, Dubois M, Leduc R, Modzelewski R, Decazes P, Morin F, Vera P, et al. Development of Novel ¹¹¹-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours. Biomolecules. 2020; 10(3):471. https://doi.org/10.3390/biom10030471

Poret, Benjamin, Laurence Desrues, Marc-André Bonin, Martin Pedard, Martine Dubois, Richard Leduc, Romain Modzelewski, Pierre Decazes, Fabrice Morin, Pierre Vera, and et al. 2020. "Development of Novel ¹¹¹-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours" Biomolecules 10, no. 3: 471. https://doi.org/10.3390/biom10030471

Poret, B., Desrues, L., Bonin, M.-A., Pedard, M., Dubois, M., Leduc, R., Modzelewski, R., Decazes, P., Morin, F., Vera, P., Castel, H., Bohn, P., & Gandolfo, P. (2020). Development of Novel ¹¹¹-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours. Biomolecules, 10(3), 471. https://doi.org/10.3390/biom10030471